what are the risks of glp 1 drugs GLP-1 and Eating Disorders: A Hidden Risk in Weight Loss Revolution – The Chicago Council on Science and Technology Long-Term Effects Of GLP-1 Medications:
Description
Given this, it is reasonable to conclude that treatment with top dose phentermine and topiramate, which is associated with a weight reduction of 11 %, would achieve an improvement in MASLD in adolescents
48 LiQ.JiaM.YanZ.LiQ.SunF.HeC.et al (2021)
(2) AMERICAN DIABETES ASSOCIATION STANDARDS OF MEDICAL CARE IN DIABETES2017 [Full Text PDF]
Recent shortages have frustrated patients, proving that logistics are as critical as innovation
Without a thoughtful nutrition and lifestyle strategy, GLP-1 users risk losing muscle and bone mass as well
SAS codes for the calculation of these weights can be found in the supplementary appendix
